KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Research & Development (2021 - 2026)

Hims & Hers Health's Research & Development history spans 6 years, with the latest figure at $46.9 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 56.9% to $46.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $166.3 million, a 78.06% increase, with the full-year FY2025 number at $149.3 million, up 89.42% from a year prior.
  • Research & Development hit $46.9 million in Q1 2026 for Hims & Hers Health, up from $41.0 million in the prior quarter.
  • Over the last five years, Research & Development for HIMS hit a ceiling of $46.9 million in Q1 2026 and a floor of $6.1 million in Q1 2022.
  • Historically, Research & Development has averaged $20.7 million across 5 years, with a median of $15.3 million in 2024.
  • Biggest five-year swings in Research & Development: rose 27.8% in 2022 and later surged 102.89% in 2025.
  • Tracing HIMS's Research & Development over 5 years: stood at $8.3 million in 2022, then surged by 61.29% to $13.4 million in 2023, then soared by 77.17% to $23.7 million in 2024, then soared by 72.48% to $41.0 million in 2025, then rose by 14.58% to $46.9 million in 2026.
  • Business Quant data shows Research & Development for HIMS at $46.9 million in Q1 2026, $41.0 million in Q4 2025, and $40.6 million in Q3 2025.